Administration of a Nondepleting Anti-CD4 Monoclonal Antibody (W3/25) Prevents Adjuvant Arthritis, Even upon Rechallenge: Parallel Administration of a Depleting Anti-CD8 Monoclonal Antibody (OX8) Does Not Modify the Effect of W3/25 (Q61472064)
Jump to navigation
Jump to search
scientific article published on 01 October 1995
Language | Label | Description | Also known as |
---|---|---|---|
English | Administration of a Nondepleting Anti-CD4 Monoclonal Antibody (W3/25) Prevents Adjuvant Arthritis, Even upon Rechallenge: Parallel Administration of a Depleting Anti-CD8 Monoclonal Antibody (OX8) Does Not Modify the Effect of W3/25 |
scientific article published on 01 October 1995 |
Statements
Administration of a nondepleting anti-CD4 monoclonal antibody (W3/25) prevents adjuvant arthritis, even upon rechallenge: parallel administration of a depleting anti-CD8 monoclonal antibody (OX8) does not modify the effect of W3/25 (English)
M Paz Morante
C Castellote